Literature DB >> 26116230

Metformin regulates stromal-epithelial cells communication via Wnt2/β-catenin signaling in endometriosis.

Hui Zhang1, Jing Xue1, Mingjiang Li1, Xingbo Zhao1, Deying Wei1, Changzhong Li2.   

Abstract

In previous studies, we found that endometriotic stromal cells lose the ability to regulate cell survival signaling in endometriotic epithelial cells. Here, we invested the effect of Metformin on the stromal-epithelial cells crosstalk in endometriosis and explored the pathway that might be involved. We found that ectopic endometriotic stromal cells (ESC) expressed and secreted higher Wnt2 protein compared with normal endometrial stromal cells (NSC). Conditioned medium (CM) from ESC supplemented with Wnt2 antibody significantly inhibited the growth of normal endometrial epithelial cells (NEC), while CM from ESC per se showed no significant effect on the growth of NEC. Metformin decreased the expression and secretion of Wnt2 in ESC. CM from Metformin-pretreated ESC significantly inhibited the growth of NEC. In conclusion, Wnt2/β-catenin signaling was involved in stromal-epithelial cells interaction in endometriosis. Metformin might regulate the stroma-epithelium communication via Wnt2-mediated signaling in endometriosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Endometriosis; Metformin; Stroma-epithelium communication; Wnt2/β-catenin

Mesh:

Substances:

Year:  2015        PMID: 26116230     DOI: 10.1016/j.mce.2015.06.011

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

Review 1.  Epithelial-to-mesenchymal transition in the development of endometriosis.

Authors:  Yan-Meng Yang; Wan-Xi Yang
Journal:  Oncotarget       Date:  2017-06-20

2.  MicroRNA expression analysis in endometriotic serum treated mesenchymal stem cells.

Authors:  Mazen Abdel-Rasheed; Ghada Nour Eldeen; Marwa Mahmoud; Mahmoud ElHefnawi; Nourhan Abu-Shahba; Mohamed Reda; Khaled Elsetohy; Michael Nabil; Amr Elnoury; Tamer Taha; Osama Azmy
Journal:  EXCLI J       Date:  2017-06-14       Impact factor: 4.068

3.  Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.

Authors:  Dian-Hui Xiu; Gui-Feng Liu; Shao-Nan Yu; Long-Yun Li; Guo-Qing Zhao; Lin Liu; Xue-Feng Li
Journal:  J Exp Clin Cancer Res       Date:  2019-02-21

4.  Metformin-activated AMPK regulates β-catenin to reduce cell proliferation in colon carcinoma RKO cells.

Authors:  Song Yi Park; Dasarang Kim; Sun-Ho Kee
Journal:  Oncol Lett       Date:  2019-01-04       Impact factor: 2.967

5.  Changing prostaglandin E2 (PGE2) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE2 receptor EP2 and EP4.

Authors:  Qingqing Huang; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2021-12-02

6.  Editorial: Current Innovations in Non-invasive Diagnoses and/or Surgical Treatments of Endometriosis.

Authors:  Jean Marc Ayoubi
Journal:  Front Surg       Date:  2021-11-25

Review 7.  Metformin as a Potential Treatment Option for Endometriosis.

Authors:  Żaneta Kimber-Trojnar; Dominik Franciszek Dłuski; Magdalena Wierzchowska-Opoka; Monika Ruszała; Bożena Leszczyńska-Gorzelak
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

8.  Metformin Alleviates Endometriosis and Potentiates Endometrial Receptivity via Decreasing VEGF and MMP9 and Increasing Leukemia Inhibitor Factor and HOXA10.

Authors:  Jing Cheng; Chunyang Li; Yingfen Ying; Jieqiang Lv; Xianqin Qu; Eileen McGowan; Yiguang Lin; Xueqiong Zhu
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

Review 9.  Wnt Signaling Pathways: A Role in Pain Processing.

Authors:  Yiting Tang; Yupeng Chen; Rui Liu; Weidong Li; Baojin Hua; Yanju Bao
Journal:  Neuromolecular Med       Date:  2022-01-24       Impact factor: 4.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.